Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic

被引:2
|
作者
Ali, Amjad [1 ]
Waqar, Muhammad [2 ,3 ]
Akram, Ayesha [4 ]
Rafique, Shazia [5 ]
Rehman, Gauhar [6 ]
Idrees, Muhammad [2 ,5 ,7 ]
Halim, Sobia Ahsan [8 ]
Waqas, Muhammad [1 ,8 ]
Uddin, Jalal [9 ]
Gojayev, Anar [10 ]
Khan, Ajmal [8 ]
Al-Harrasi, Ahmed [8 ]
机构
[1] Hazara Univ Mansehra, Dept Biotechnol & Genet Engn, Khyber Pakhtunkhwa, Pakistan
[2] Genome Ctr Mol Based Diagnost & Res GCMBDR Lahore, Lahore, Pakistan
[3] Quaid E Azam Univ Islamabad, Dept Biotechnol, Islamabad, Pakistan
[4] Univ Punjab, Mol Virol Lab Ctr Appl Mol Biol CAMB, 87-West Canal Bank Rd Thokar Niaz Baig, Lahore, Pakistan
[5] Univ Punjab, Ctr Excellence Mol Biol CEMB, Div Mol Virol, 87 West Canal Bank Rd Thokar Niaz Baig, Lahore, Pakistan
[6] Category D Hosp Talash Dir Lower, Malakand Div, Khyber Pakhtunkhwa, Pakistan
[7] Univ Peshawar, Khyber Pakhtunkhwa, Pakistan
[8] Univ Nizwa, Nat & Med Sci Res Ctr, Birkat Al Mou 616,POB 33, Nizwa, Oman
[9] King Khalid Univ, Coll Pharm, Dept Pharmaceut Chem, Abha 62529, Saudi Arabia
[10] ADA Univ, Sch Educ, Gen Educ Program, Ahmadbey Aghaoghlu str 11, AZ-1008 Baku, Azerbaijan
关键词
Seroepidemiology; SARS-CoV-2; IgG; Antibodies; Malakand; Pakistan; CORONAVIRUS;
D O I
10.1016/j.jiph.2023.05.036
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Aim: This study aimed to assess the seroprevalence of SARS-CoV-2 and disease symptoms in Malakand, Pakistan.Materials & method: 623 samples with suspected SARS-CoV-2 were collected from different regions of Malakand and analyzed to detect SARS-CoV-2 IgG antibodies using ELISA.Results: 306 (49.1%) 0 f 623 patients were anti-SARS-CoV-2 IgG reactive, with a higher prevalence in males (75%) than females (25%). In this study, we enrolled two groups, subjects working in a non-medical setting and subjects working in a medical setting. Clinical symptoms were statistically linked with SARS-CoV-2. Four weeks of follow-up analysis of IgG titers in health care workers showed an increase in IgG antibodies titer.Conclusion: This study gives insights into the community-based spread of SARS-CoV-2 infection, associated immunity, and herd immunity in the studied population. This study can provide insights to the government about early vaccination of this population as most of the population is not yet vaccinated.& COPY; 2023 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:1256 / 1261
页数:6
相关论文
共 50 条
  • [21] Editorial: Impact of the SARS-CoV-2 pandemic on the evolution and epidemiology of other viruses
    Rodriguez-Morales, Alfonso J.
    Velasco-Hernandez, Jorge X.
    Comas-Garcia, Andreu
    FRONTIERS IN VIROLOGY, 2024, 4
  • [22] Tracheotomy in the SARS-CoV-2 pandemic
    Skoog, Hunter
    Withrow, Kirk
    Jeyarajan, Harishanker
    Greene, Benjamin
    Batra, Hitesh
    Cox, Daniel
    Pierce, Albert
    Grayson, Jessica W.
    Carroll, William R.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2020, 42 (07): : 1392 - 1396
  • [23] The role of epidemiology in the SARS-CoV-2 pandemic: meaning, tasks, methods, and findings
    Pigeot, Iris
    Gleich, Sabine
    Grabenhenrich, Linus
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2021, 64 (09) : 1047 - 1049
  • [24] PREGNANCY AND THE SARS-COV-2 PANDEMIC
    Reynolds, Rebecca M.
    Stock, Sarah J.
    Denison, Fiona C.
    Maybin, Jacqueline A.
    Critchley, Hilary O. D.
    PHYSIOLOGICAL REVIEWS, 2022, 102 (03) : 1385 - 1391
  • [25] Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view
    Abduljalil, J. M.
    Abduljalil, B. M.
    NEW MICROBES AND NEW INFECTIONS, 2020, 35
  • [26] Genomic and spatial epidemiology: lessons learned from SARS-CoV-2 pandemic
    Choi, Yangji
    De Ridder, David
    Greub, Gilbert
    CURRENT OPINION IN HIV AND AIDS, 2025, 20 (03) : 287 - 293
  • [27] Seroprevalence and SARS-CoV-2 testing in healthcare occupations
    Ziemssen, Focke
    Bayyoudl, Tarek
    Bartz-Schmidt, Karl Ulrich
    Peter, Andreas
    Ueffing, Marius
    OPHTHALMOLOGE, 2020, 117 (07): : 631 - 637
  • [28] SARS-CoV-2 Seroprevalence Studies in Pets, Spain
    Barroso-Arevalo, Sandra
    Sanchez-Morales, Lidia
    Barasona, Jose A.
    Dominguez, Lucas
    Sanchez-Vizcaino, Jose M.
    EMERGING INFECTIOUS DISEASES, 2023, 29 (06) : 1136 - 1142
  • [29] SeroTracker: a global SARS-CoV-2 seroprevalence dashboard
    Arora, Rahul K.
    Joseph, Abel
    Van Wyk, Jordan
    Rocco, Simona
    Atmaja, Austin
    May, Ewan
    Yan, Tingting
    Bobrovitz, Niklas
    Chevrier, Jonathan
    Cheng, Matthew P.
    Williamson, Tyler
    Buckeridge, David L.
    LANCET INFECTIOUS DISEASES, 2020, 21 (04): : E75 - E76
  • [30] Seroprevalence of SARS-CoV-2 antibodies in South Korea
    Lee, Kwangmin
    Jo, Seongil
    Lee, Jaeyong
    JOURNAL OF THE KOREAN STATISTICAL SOCIETY, 2021, 50 (03) : 891 - 904